gTADA

Division of Psychiatric Genomics, Department of Genetics and Genomic Sciences, Institute for Genomics and Multiscale Biology, Icahn School of Medicine at Mount Sinai, New York, NY, USA; Charles Bronfman Institute for Personalized Medicine, Icahn School of Medicine at Mount Sinai, New York, NY, USA; Department of Medical Epidemiology and Biostatistics, Karolinska Institutet, Stockholm, Sweden; Laboratory of Molecular Neurobiology, Department of Medical Biochemistry and Biophysics, Karolinska Institutet, Stockholm, Sweden; Division of Genetic Medicine, Departments of Medicine, Psychiatry and Biomedical Informatics, Vanderbilt Genetics Institute, Vanderbilt University Medical Center, Nashville, TN, USA; Seaver Autism Center, Department of Psychiatry, Icahn School of Medicine at Mount Sinai, New York, NY, USA; Verily Life Sciences, San Francisco, CA, USA; Sleep Center, Brigham and Women's Hospital, Harvard Medical School, Boston, MA, USA; Department of Functional Genomics, The Center for Neurogenomics and Cognitive Research, Vrije Universiteit University and Vrije Universiteit Medical Center, Amsterdam, The Netherlands; Department of Molecular and Cellular Neurobiology, The Center for Neurogenomics and Cognitive Research, Vrije Universiteit University, Amsterdam, The Netherlands; The Mindich Child Health & Development Institute, Icahn School of Medicine at Mount Sinai, New York, NY, USA; Friedman Brain Institute, Icahn School of Medicine at Mount Sinai, New York, NY, USA; Department of Human Genetics, University of Chicago, Chicago, IL, USA; Departments of Genetics and Psychiatry, University of North Carolina, Chapel Hill, NC, USA; Stanley Center for Psychiatric Research, Broad Institute of MIT and Harvard, Cambridge, MA, USA

Supported by NIH grant R01MH105554 and by NIH grant R01MH110555.